Botanix Pharmaceuticals Ltd (BOT) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.591x

Based on the latest financial reports, Botanix Pharmaceuticals Ltd (BOT) has a cash flow conversion efficiency ratio of -0.591x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-48.02 Million ≈ $-33.98 Million USD) by net assets (AU$81.30 Million ≈ $57.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Botanix Pharmaceuticals Ltd to measure how many days the company can operate on defensive assets alone.

Botanix Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Botanix Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Botanix Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Botanix Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Averbuch Formica Center Ltd
TA:AVER
0.047x
BIONXT SOLUTIONS INC.
F:BXT
0.244x
Eldav-L
TA:ELDAV
0.022x
Petrolia SE
F:0PE
0.038x
ML System S.A.
WAR:MLS
0.093x
Drax Group PLC
LSE:DRX
0.144x
Stakeholder Gold Corp
V:SRC
-0.016x
Net Digital AG
XETRA:VRL
-0.042x

Annual Cash Flow Conversion Efficiency for Botanix Pharmaceuticals Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Botanix Pharmaceuticals Ltd from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Botanix Pharmaceuticals Ltd (BOT) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$81.30 Million
≈ $57.52 Million
AU$-78.58 Million
≈ $-55.60 Million
-0.967x -1193.21%
2024-06-30 AU$108.73 Million
≈ $76.94 Million
AU$-8.13 Million
≈ $-5.75 Million
-0.075x +85.79%
2023-06-30 AU$22.95 Million
≈ $16.24 Million
AU$-12.07 Million
≈ $-8.54 Million
-0.526x +61.66%
2022-06-30 AU$8.15 Million
≈ $5.77 Million
AU$-11.18 Million
≈ $-7.91 Million
-1.372x -861.49%
2021-06-30 AU$20.80 Million
≈ $14.72 Million
AU$-2.97 Million
≈ $-2.10 Million
-0.143x +80.57%
2020-06-30 AU$23.64 Million
≈ $16.72 Million
AU$-17.36 Million
≈ $-12.28 Million
-0.734x +96.56%
2019-06-30 AU$615.22K
≈ $435.30K
AU$-13.14 Million
≈ $-9.30 Million
-21.360x -3410.32%
2018-06-30 AU$16.28 Million
≈ $11.52 Million
AU$-9.91 Million
≈ $-7.01 Million
-0.608x +28.70%
2017-06-30 AU$5.44 Million
≈ $3.85 Million
AU$-4.64 Million
≈ $-3.28 Million
-0.853x -40490.24%
2016-06-30 AU$3.18 Million
≈ $2.25 Million
AU$-6.69K
≈ $-4.73K
-0.002x +99.79%
2015-06-30 AU$1.23 Million
≈ $869.58K
AU$-1.20 Million
≈ $-851.81K
-0.980x -70.31%
2014-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-1.29 Million
≈ $-913.02K
-0.575x -238.34%
2013-06-30 AU$-2.50 Million
≈ $-1.77 Million
AU$-1.04 Million
≈ $-735.77K
0.416x -13.19%
2012-06-30 AU$-2.33 Million
≈ $-1.65 Million
AU$-1.12 Million
≈ $-790.81K
0.479x +54.21%
2011-06-30 AU$-2.23 Million
≈ $-1.58 Million
AU$-692.97K
≈ $-490.32K
0.311x -35.20%
2010-06-30 AU$-1.80 Million
≈ $-1.27 Million
AU$-861.12K
≈ $-609.30K
0.479x +125.99%
2009-06-30 AU$877.74K
≈ $621.06K
AU$-1.62 Million
≈ $-1.15 Million
-1.844x +0.15%
2008-06-30 AU$1.29 Million
≈ $909.99K
AU$-2.38 Million
≈ $-1.68 Million
-1.847x -94.45%
2007-06-30 AU$2.90 Million
≈ $2.05 Million
AU$-2.75 Million
≈ $-1.95 Million
-0.950x +29.94%
2006-06-30 AU$2.22 Million
≈ $1.57 Million
AU$-3.01 Million
≈ $-2.13 Million
-1.356x -64.76%
2005-06-30 AU$3.46 Million
≈ $2.45 Million
AU$-2.84 Million
≈ $-2.01 Million
-0.823x -213.18%
2004-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-589.68K
≈ $-417.24K
-0.263x +9.32%
2002-06-30 AU$4.05 Million
≈ $2.86 Million
AU$-1.17 Million
≈ $-829.68K
-0.290x -395.90%
2001-06-30 AU$5.69 Million
≈ $4.03 Million
AU$-332.70K
≈ $-235.40K
-0.058x +80.44%
2000-06-30 AU$5.15 Million
≈ $3.64 Million
AU$-1.54 Million
≈ $-1.09 Million
-0.299x +45.25%
1999-06-30 AU$8.08 Million
≈ $5.72 Million
AU$-4.41 Million
≈ $-3.12 Million
-0.546x -218.85%
1998-06-30 AU$15.75 Million
≈ $11.15 Million
AU$7.23 Million
≈ $5.12 Million
0.459x +547.35%
1997-06-30 AU$32.05 Million
≈ $22.67 Million
AU$-3.29 Million
≈ $-2.33 Million
-0.103x -8556.45%
1996-06-30 AU$37.91 Million
≈ $26.83 Million
AU$46.00K
≈ $32.55K
0.001x -99.25%
1995-06-30 AU$38.44 Million
≈ $27.20 Million
AU$6.24 Million
≈ $4.42 Million
0.162x +68.58%
1994-06-30 AU$26.04 Million
≈ $18.43 Million
AU$2.51 Million
≈ $1.78 Million
0.096x +25.35%
1993-06-30 AU$18.35 Million
≈ $12.98 Million
AU$1.41 Million
≈ $997.66K
0.077x -39.42%
1992-06-30 AU$11.41 Million
≈ $8.07 Million
AU$1.45 Million
≈ $1.02 Million
0.127x -15.46%
1991-06-30 AU$12.88 Million
≈ $9.11 Million
AU$1.93 Million
≈ $1.37 Million
0.150x --

About Botanix Pharmaceuticals Ltd

AU:BOT Australia Biotechnology
Market Cap
$30.68 Million
AU$43.35 Million AUD
Market Cap Rank
#23747 Global
#925 in Australia
Share Price
AU$0.02
Change (1 day)
-4.35%
52-Week Range
AU$0.02 - AU$0.34
All Time High
AU$0.52
About

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment o… Read more